Discover how IQoro uses neuromuscular training to treat the root causes of reflux and other health conditions by tapping into the body’s neuroplasticity.
Introduction and Background of the IQoro
Josef Kreitmayer
Welcome to another wonderful session at the Reflux Summit. We have two incredible guests with us today: Dr. Mary Hägg and Ylvali Gerling.
Josef Kreitmayer
Dr. Mary Hägg is a scientist, innovator, and registered dentist with significant contributions in experimental ear, nose, and throat diseases. She has worked for 12 years as a hospital dentist and 31 years as head of the Speech and Swallowing Center at Hudiksvall Hospital. Her research at Uppsala University focuses on neuromuscular training for conditions like reflux, sleep apnea, and facial paralysis.
Josef Kreitmayer
Ylvali Gerling is the CEO of MYoroface AB, the company behind the IQoro device, which she co-founded with Dr. Hägg and their daughter and sister Lynn Hägg in 2012.
Josef Kreitmayer
The IQoro device was initially created to help post-stroke patients, but its applications have expanded. It addresses reflux, swallowing difficulties, snoring, and sleep apnea by stimulating the neuromuscular system through the mouth and activating neuroplasticity to restore lost function.
How IQoro Works
Ylvali Gerling
IQoro is a neuromuscular training device that communicates with the brainstem and cerebral cortex, triggering neuroplasticity and enabling the recovery of lost muscle and nerve function. It treats the root causes of reflux, snoring, swallowing issues, and other conditions by restoring the functionality of critical muscles.
Training takes just 90 seconds a day, with no side effects, medication, or surgery needed.
The device emerged from frustration with ineffective traditional treatments. Observing how infants explore their surroundings using their mouths inspired researchers to use the oral cavity to access the brainstem and stimulate multiple functions.
One compelling early case involved a man who, after a double stroke, could not speak or swallow. After using IQoro for three months, he regained facial control and speech and could sit upright and swallow again.
The method involves placing the device in the mouth, pressing the lips together, then gently pulling it forward while relaxing the jaw and tongue. The pull is held for 10 seconds, repeated three times per session, three times daily. This stimulates the entire chain of muscles from the lips to the diaphragm.
Josef Kreitmayer
Using the device, I could feel deep muscle activation, even below the throat area. It was a powerful sensation.
Conditions Treated and Who Benefits
Ylvali Gerling
IQoro helps with acid reflux, sleep apnea, and snoring—all linked to muscle weakness. These conditions often coexist. Most patients focus on one issue, but underlying muscular problems can cause multiple symptoms.
Many people are unaware that they snore or suffer from sleep apnea. Research shows millions of people globally experience these conditions, including many women who are undiagnosed.
Sleep apnea occurs when weakened muscles block the airways during sleep. Similarly, reflux stems from weak muscles around the diaphragm, allowing stomach acid to rise. IQoro strengthens the muscle chain from the lips to the diaphragm, addressing the root causes.
Training Frequency, Results, and Medication Use
Ylvali Gerling
Users train daily for 30 seconds per session, three times a day. Improvement varies. Some regain normal swallowing in five weeks, while others need more time. About 40% of reflux sufferers see results within a month. Consistency is key.
Factors like long-standing issues or the use of muscle relaxants, including alcohol, can slow progress. In clinical studies, 97% of patients improved, and 61% of reflux sufferers became symptom-free and stopped using acid-suppressing medications.
Practical Use and Accessibility
Ylvali Gerling
The device is easy to incorporate into daily routines, such as before meals or brushing teeth. A mobile app helps users stay consistent with reminders.
IQoro’s effectiveness does not vary by body type, gender, or age. Studies show similar results across groups, including individuals with severe obesity and older adults.
Hygiene and Distribution
Ylvali Gerling
IQoro should be rinsed after each use. It can be cleaned with mild soap or occasionally placed in the dishwasher.
Due to hygiene considerations, its CE marking covers one year of use. Users should check the device for wear and replace it annually.
Over 150,000 customers use IQoro, and more than 100 NHS hospitals in the UK prescribe it.
Customer Feedback and Life Impact
Ylvali Gerling
Feedback is overwhelmingly positive. Many users report that IQoro gave them their lives back.
One man in Denmark, after years of depression and failed treatments, used IQoro and regained the ability to travel on his honeymoon.
The device’s simplicity is its strength. While it may seem too easy to be effective, it delivers powerful results when used consistently.
Contraindications and Cautions
Ylvali Gerling
IQoro is generally safe. However, people with trigeminal neuralgia, paraesophageal hernia, or achalasia cardia should begin training slowly, starting with shorter pull durations.
It does not cause tinnitus but may alter its tone. Individuals with Bell’s palsy or whiplash injuries should also proceed cautiously.
The company provides online resources and support to guide safe use.
Science and Research Behind IQoro
Ylvali Gerling
Extensive research underpins IQoro. Dr. Hägg developed a lip force meter to measure the required strength for effective muscle training.
Studies determined that 10 seconds per pull, repeated three times, is optimal. Overtraining can weaken the delicate muscles involved.
The device activates both voluntary and involuntary muscles through nerves like the trigeminal and vagus. Pulling the device stimulates areas from the lips to the soft palate and diaphragm, engaging core swallowing and breathing functions.
Treating Hiatal Hernias and Strengthening the Diaphragm
Ylvali Gerling
Hiatal hernias occur when the stomach slips upward through the diaphragm. Strengthening the muscle chain helps restore the stomach to its proper position and reinforces the lower esophageal sphincter.
This reduces reflux without the need for surgery.
Broader Physiological Impact
Ylvali Gerling
By stimulating the vagus nerve, IQoro may help regulate heart rate, inflammation, and chronic conditions such as Crohn’s disease.
While more research is needed, clinical observations suggest promising systemic benefits.
Role in Healthcare and Comparison to Surgery or PPIs
Ylvali Gerling
IQoro complements medications like PPIs and can reduce the need for surgery.
Many patients use it while awaiting surgery and later find the procedure is no longer necessary.
Its non-invasive nature makes it a low-risk, cost-effective alternative.
Healthcare System Integration and Expansion
Ylvali Gerling
IQoro has been reimbursed by the NHS in the UK since May 2022.
Adoption remains slow due to limited awareness and systemic inertia.
Wider European distribution is active, but North American expansion is constrained by regulatory and cost barriers, despite patent protection in 29 countries.
Cost, Lifespan, and Final Advice
Ylvali Gerling
IQoro is CE marked for one year of use due to hygiene requirements. While it may last longer, users should inspect it regularly.
Compared to the long-term cost of medication or surgery, it is a worthwhile investment.
The IQoro website offers detailed information and instructional videos. Many users report gaining more clarity there than from years of doctor visits.
Reflux is a serious condition. While no solution works for everyone, it’s essential to take action and find what works for you.
